![](/img/cover-not-exists.png)
A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
Gupta, Vikas, Mesa, Ruben A., Deininger, Michael W.N., Rivera, Candido E., Sirhan, Shireen, Brachmann, Carrie Baker, Collins, Helen, Kawashima, Jun, Xin, Yan, Verstovsek, SrdanVolume:
102
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2016.148924
Date:
January, 2017
File:
PDF, 1.28 MB
english, 2017